NCT02879071

Brief Summary

The time-frame and the follow-up elements after embolization of brain arteriovenous malformations are not standardized. Therefore, few reliable follow-up data are available for these patients. This study aims at collecting standardized long term data for these patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
141mo left

Started Nov 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Nov 2015Nov 2037

Study Start

First participant enrolled

November 26, 2015

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 22, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 25, 2016

Completed
21.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2037

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2037

Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

22 years

First QC Date

August 22, 2016

Last Update Submit

January 21, 2026

Conditions

Arteriovenous Malformations

Outcome Measures

Primary Outcomes (1)

  • angiographic evaluation of the arteriovenous malformation occlusion

    5 years after embolization

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing embolization for an arteriovenous malformation

You may qualify if:

  • arteriovenous malformation
  • age \> 18 years old

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Ophtalmologique Adolphe de Rothschild

Paris, 75019, France

RECRUITING

Related Publications (2)

  • Baharvahdat H, Blanc R, Fahed R, Pooyan A, Mowla A, Escalard S, Delvoye F, Desilles JP, Redjem H, Ciccio G, Smajda S, Hamdani M, Mazighi M, Piotin M. Endovascular treatment as the main approach for Spetzler-Martin grade III brain arteriovenous malformations. J Neurointerv Surg. 2021 Mar;13(3):241-246. doi: 10.1136/neurintsurg-2020-016450. Epub 2020 Sep 28.

    PMID: 32989031DERIVED

  • Baharvahdat H, Blanc R, Fahed R, Smajda S, Ciccio G, Desilles JP, Redjem H, Escalard S, Mazighi M, Chauvet D, Robert T, Sasannejad P, Piotin M. Endovascular Treatment for Low-Grade (Spetzler-Martin I-II) Brain Arteriovenous Malformations. AJNR Am J Neuroradiol. 2019 Apr;40(4):668-672. doi: 10.3174/ajnr.A5988. Epub 2019 Feb 21.

    PMID: 30792251DERIVED

MeSH Terms

Conditions

Arteriovenous Malformations

Condition Hierarchy (Ancestors)

Vascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Amélie Yavchitz, MD

CONTACT

+33 1 48 03 64 54ayachitz@for.paris

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2016

First Posted

August 25, 2016

Study Start

November 26, 2015

Primary Completion (Estimated)

November 25, 2037

Study Completion (Estimated)

November 25, 2037

Last Updated

January 22, 2026

Record last verified: 2026-01

Locations

FR(1)